Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2023

The forecast has been updated: December 3, 2021 9:28


Biohaven Pharmaceutical Holding stock price online today

Analyst Target Price

152

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Biohaven Pharmaceutical Holding stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? Biohaven Pharmaceutical Holding stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $152 target price for Biohaven Pharmaceutical Holding stock stock.

Today 200 Day Moving Average is the support level (105.18 $).

50 Day Moving Average is the resistance level (131.38 $).




BHVN Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 110.90 102.12 117.61 13.17 %
Feb 108.22 103.58 113.81 8.99 %
Mar 107.62 102.53 113.66 9.79 %
Apr 109.40 106.63 116.74 8.66 %
May 117.82 107.45 126.51 15.06 %
Jun 120.29 116.18 126.64 8.25 %
Jul 118.83 114.78 122.88 6.60 %
Aug 122.23 114.03 127.07 10.26 %
Sep 109.86 105.87 116.99 9.50 %
Oct 108.17 104.24 112.57 7.40 %
Nov 99.24 91.38 103.39 11.61 %
Dec 102.85 98.89 105.45 6.22 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Biohaven Pharmaceutical Holding stock.


Biohaven Pharmaceutical Holding overview

Biohaven Pharmaceutical Holding Address

215 CHURCH STREET, NEW HAVEN, CT, US

Market Capitalization

7 357 102 000 $

EBITDA

-356 321 504

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-13.7

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

6.68

Trailing PE

-

Forward PE

-

EV To Revenue

24.24

EV To EBITDA

-

52 Week High

151.51

52 Week Low

62.57

50 Day Moving Average

131.38

200 Day Moving Average

105.18

Shares Outstanding

65501000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Biohaven Pharmaceutical Holding stock forecast for this year


Biohaven Pharmaceutical Holding stock forecast for Jan 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 110.90. Positive monthly dynamics of the instrument is expected with 13.173% volatility is expected.

Pessimistic forecast: 102.12

Optimistic: 117.61


Biohaven Pharmaceutical Holding stock forecast for Feb 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 108.22. Negative monthly dynamics of the instrument is expected with 8.995% volatility is expected.

Pessimistic forecast: 103.58

Optimistic: 113.81


Biohaven Pharmaceutical Holding stock forecast for Mar 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 107.62. Negative monthly dynamics of the instrument is expected with 9.791% volatility is expected.

Pessimistic forecast: 102.53

Optimistic: 113.66


Biohaven Pharmaceutical Holding stock forecast for Apr 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 109.40. Positive monthly dynamics of the instrument is expected with 8.659% volatility is expected.

Pessimistic forecast: 106.63

Optimistic: 116.74


Biohaven Pharmaceutical Holding stock forecast for May 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 117.82. Positive monthly dynamics of the instrument is expected with 15.060% volatility is expected.

Pessimistic forecast: 107.45

Optimistic: 126.51


Biohaven Pharmaceutical Holding stock forecast for Jun 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 120.29. Positive monthly dynamics of the instrument is expected with 8.254% volatility is expected.

Pessimistic forecast: 116.18

Optimistic: 126.64


Biohaven Pharmaceutical Holding stock forecast for Jul 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 118.83. Negative monthly dynamics of the instrument is expected with 6.596% volatility is expected.

Pessimistic forecast: 114.78

Optimistic: 122.88


Biohaven Pharmaceutical Holding stock forecast for Aug 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 122.23. Positive monthly dynamics of the instrument is expected with 10.263% volatility is expected.

Pessimistic forecast: 114.03

Optimistic: 127.07


Biohaven Pharmaceutical Holding stock forecast for Sep 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 109.86. Negative monthly dynamics of the instrument is expected with 9.503% volatility is expected.

Pessimistic forecast: 105.87

Optimistic: 116.99


Biohaven Pharmaceutical Holding stock forecast for Oct 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 108.17. Negative monthly dynamics of the instrument is expected with 7.399% volatility is expected.

Pessimistic forecast: 104.24

Optimistic: 112.57


Biohaven Pharmaceutical Holding stock forecast for Nov 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 99.24. Negative monthly dynamics of the instrument is expected with 11.614% volatility is expected.

Pessimistic forecast: 91.38

Optimistic: 103.39


Biohaven Pharmaceutical Holding stock forecast for Dec 2023.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 102.85. Positive monthly dynamics of the instrument is expected with 6.222% volatility is expected.

Pessimistic forecast: 98.89

Optimistic: 105.45



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 130.27 (03.12.2021) 1.47 %
AbbVie Inc.
ABBV 118.85 (03.12.2021) 1.69 %
Aeterna Zentaris Inc.
AEZS 0.4 (03.12.2021) -7.21 %
Allakos Inc.
ALLK 74.02 (03.12.2021) -3.10 %
Allogene Therapeutics, Inc.
ALLO 17.62 (03.12.2021) -7.70 %
Amgen Inc.
AMGN 202.44 (03.12.2021) 0.63 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 17.09 (03.12.2021) -5.11 %
Aurora Cannabis Inc.
ACB 5.82 (03.12.2021) -5.21 %
Becton Dickinson and Company
BDX 244.12 (03.12.2021) 0.90 %
Biogen Inc.
BIIB 223.92 (03.12.2021) -2.01 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 103.56 (03.12.2021) -5.24 %
BioNTech SE
BNTX 344.06 (03.12.2021) 3.17 %
bluebird bio, Inc.
BLUE 9.95 (03.12.2021) -6.40 %
Boston Scientific Corp.
BSX 39.46 (03.12.2021) -0.35 %
Bristol-Myers Squibb Company
BMY 56.32 (03.12.2021) 1.64 %
Canopy Growth Corp.
CGC 9.99 (03.12.2021) -3.57 %
Castle Biosciences, Inc.
CSTL 41.43 (03.12.2021) -1.17 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 245.58 (03.12.2021) -0.93 %
Emergent BioSolutions Inc.
EBS 41.89 (03.12.2021) -1.94 %
Exelixis, Inc.
EXEL 15.84 (03.12.2021) -3.88 %
G1 Therapeutics, Inc.
GTHX 10.65 (03.12.2021) -11.69 %
Gilead Sciences, Inc.
GILD 69.56 (03.12.2021) -0.16 %
GlaxoSmithKline plc
GSK 41.25 (03.12.2021) -0.53 %
GoodRx Holdings, Inc.
GDRX 38.42 (03.12.2021) -3.13 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 65.78 (03.12.2021) -1.28 %
Inovio Pharmaceuticals, Inc.
INO 6.17 (03.12.2021) -6.66 %
Johnson & Johnson
JNJ 159.38 (03.12.2021) 1.46 %
Medtronic plc.
MDT 106.87 (03.12.2021) -0.38 %
Merck & Co., Inc.
MRK 73.34 (03.12.2021) -0.74 %
Moderna, Inc.
MRNA 306.72 (03.12.2021) 1.73 %
Novartis AG
NVS 80 (03.12.2021) 0.06 %
Novavax, Inc.
NVAX 160.48 (03.12.2021) -0.92 %
ObsEva SA
OBSV 2.02 (03.12.2021) -4.27 %
OrganiGram Holdings Inc.
OGI 1.82 (03.12.2021) -6.67 %
Pfizer Inc.
PFE 54.27 (03.12.2021) 2.32 %
Regeneron Pharmaceuticals, Inc.
REGN 635.16 (03.12.2021) 0.18 %
Sanofi
SNY 47.07 (03.12.2021) -1.30 %
Schrodinger, Inc.
SDGR 36.33 (03.12.2021) -4.97 %
Senseonics Holdings, Inc.
SENS 2.69 (03.12.2021) -5.94 %
Sorrento Therapeutics, Inc.
SRNE 4.945 (03.12.2021) -10.25 %
Stryker Corp.
SYK 246.87 (03.12.2021) -0.21 %
Sundial Growers Inc.
SNDL 0.564 (03.12.2021) -4.73 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.05 (03.12.2021) -1.35 %
Thermo Fisher Scientific Inc.
TMO 636.11 (03.12.2021) 1.36 %
Tilray, Inc.
TLRY 8.95 (03.12.2021) -6.18 %
UnitedHealth Group, Inc.
UNH 449.32 (03.12.2021) 0.74 %
Veeva Systems Inc.
VEEV 249.49 (03.12.2021) -4.92 %
Zomedica Corp.
ZOM 0.33 (03.12.2021) -13.16 %
Zynerba Pharmaceuticals, Inc.
ZYNE 3.19 (03.12.2021) -4.49 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.